Use of healthcare services by patients with multiple sclerosis in France over 2010-2015: a nationwide population-based study using health administrative data.
France
Multiple sclerosis
administrative database
care-seeking
hospital admissions
neurologists
Journal
Multiple sclerosis journal - experimental, translational and clinical
ISSN: 2055-2173
Titre abrégé: Mult Scler J Exp Transl Clin
Pays: United States
ID NLM: 101668877
Informations de publication
Date de publication:
Historique:
received:
05
08
2019
revised:
31
10
2019
accepted:
21
11
2019
entrez:
7
1
2020
pubmed:
7
1
2020
medline:
7
1
2020
Statut:
epublish
Résumé
Most of the knowledge about people with multiple sclerosis (PwMS) in France comes from cohorts, which may suffer from recruitment bias or from the unique registry located in Lorraine, East France. To describe use of care in the French population of PwMS, over 2010-2015. All PwMS in the French national health data system (97% of the general population covered) were included. Demographics, and use of care were described (visits with general practitioners (GPs), neurologists, nurses, physiotherapists and hospitalisations). A focus on the neurological follow-up was also conducted. A total of 112,415 PwMS were identified (sex ratio F:M = 2.4, median age 46), of whom 5005 died during follow-up. The median numbers of visits with GPs and neurologists were 6.6 and 1.3 respectively per patient-year. Moreover, 53,457 (47.6%) received multiple sclerosis (MS) treatments; about 13% of patients had no neurological follow-up, and 81.8% had at least one hospitalisation. For the first time in France, this exhaustive dataset offered the opportunity to provide objective figures regarding care practices for MS at the national level, without any selection bias. It also allowed description of patients with MS according to their neurological follow-up, especially those who were absent from cohorts led by neurologists.
Sections du résumé
BACKGROUND
BACKGROUND
Most of the knowledge about people with multiple sclerosis (PwMS) in France comes from cohorts, which may suffer from recruitment bias or from the unique registry located in Lorraine, East France.
OBJECTIVE
OBJECTIVE
To describe use of care in the French population of PwMS, over 2010-2015.
METHODS
METHODS
All PwMS in the French national health data system (97% of the general population covered) were included. Demographics, and use of care were described (visits with general practitioners (GPs), neurologists, nurses, physiotherapists and hospitalisations). A focus on the neurological follow-up was also conducted.
RESULTS
RESULTS
A total of 112,415 PwMS were identified (sex ratio F:M = 2.4, median age 46), of whom 5005 died during follow-up. The median numbers of visits with GPs and neurologists were 6.6 and 1.3 respectively per patient-year. Moreover, 53,457 (47.6%) received multiple sclerosis (MS) treatments; about 13% of patients had no neurological follow-up, and 81.8% had at least one hospitalisation.
CONCLUSIONS
CONCLUSIONS
For the first time in France, this exhaustive dataset offered the opportunity to provide objective figures regarding care practices for MS at the national level, without any selection bias. It also allowed description of patients with MS according to their neurological follow-up, especially those who were absent from cohorts led by neurologists.
Identifiants
pubmed: 31903222
doi: 10.1177/2055217319896090
pii: 10.1177_2055217319896090
pmc: PMC6923529
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2055217319896090Informations de copyright
© The Author(s) 2019.
Références
Rev Neurol (Paris). 2014 Jun-Jul;170(6-7):432-9
pubmed: 24856285
Neurology. 2015 Jan 27;84(4):350-8
pubmed: 25540309
Mult Scler. 2013 Jul;19(8):1113-9
pubmed: 23263898
BMC Public Health. 2009 Jan 22;9:33
pubmed: 19161613
Can J Neurol Sci. 2007 May;34(2):167-74
pubmed: 17598593
Brain. 2019 May 1;142(5):1324-1333
pubmed: 30883636
Med Care. 2016 Feb;54(2):188-94
pubmed: 26683778
Mult Scler Relat Disord. 2018 Oct;25:186-191
pubmed: 30099203
Neuroepidemiology. 2018;51(1-2):1-10
pubmed: 29763935
J Neurol. 2017 Jun;264(6):1185-1192
pubmed: 28516332
Mult Scler J Exp Transl Clin. 2017 Sep 13;3(3):2055217317730421
pubmed: 28932411
Mult Scler. 2020 Jan;26(1):118-122
pubmed: 30541380
Rev Epidemiol Sante Publique. 2017 Oct;65 Suppl 4:S149-S167
pubmed: 28756037
Eur J Neurol. 2018 Dec;25(12):1439-1445
pubmed: 29996003
Stat Methods Med Res. 2019 Jun;28(6):1651-1663
pubmed: 29717944
Mult Scler. 2009 Feb;15(2):251-7
pubmed: 19181774
Eur J Neurol. 2016 Jun;23(6):1093-100
pubmed: 26992124
Mult Scler Relat Disord. 2015 Nov;4(6):546-54
pubmed: 26590661
Mult Scler. 2012 Sep;18(9):1244-50
pubmed: 22354740
Rev Neurol (Paris). 2018 Jun;174(6):475-479
pubmed: 29685429